ANL 33.82 Decreased By ▼ -0.43 (-1.26%)
ASC 13.44 Increased By ▲ 0.09 (0.67%)
ASL 23.15 Increased By ▲ 0.55 (2.43%)
AVN 84.20 Increased By ▲ 0.50 (0.6%)
BOP 7.73 Increased By ▲ 0.03 (0.39%)
BYCO 9.34 Decreased By ▼ -0.03 (-0.32%)
DGKC 110.00 Decreased By ▼ -0.20 (-0.18%)
EPCL 50.40 Decreased By ▼ -0.49 (-0.96%)
FCCL 22.70 Decreased By ▼ -0.06 (-0.26%)
FFBL 25.45 Decreased By ▼ -0.25 (-0.97%)
FFL 15.15 Decreased By ▼ -0.15 (-0.98%)
HASCOL 8.96 Decreased By ▼ -0.04 (-0.44%)
HUBC 79.00 No Change ▼ 0.00 (0%)
HUMNL 6.14 Increased By ▲ 0.30 (5.14%)
JSCL 19.00 Increased By ▲ 0.30 (1.6%)
KAPCO 40.07 Increased By ▲ 0.68 (1.73%)
KEL 3.68 No Change ▼ 0.00 (0%)
LOTCHEM 14.25 Decreased By ▼ -0.10 (-0.7%)
MLCF 42.53 Increased By ▲ 0.23 (0.54%)
PAEL 30.68 Decreased By ▼ -0.39 (-1.26%)
PIBTL 9.50 Increased By ▲ 0.05 (0.53%)
POWER 8.50 Increased By ▲ 0.06 (0.71%)
PPL 83.30 No Change ▼ 0.00 (0%)
PRL 22.85 Increased By ▲ 0.08 (0.35%)
PTC 9.05 Decreased By ▼ -0.15 (-1.63%)
SILK 1.37 Decreased By ▼ -0.03 (-2.14%)
SNGP 38.80 Increased By ▲ 0.21 (0.54%)
TRG 161.10 Decreased By ▼ -2.12 (-1.3%)
UNITY 34.65 Decreased By ▼ -0.28 (-0.8%)
WTL 1.48 Increased By ▲ 0.03 (2.07%)
BR100 4,808 Increased By ▲ 8.95 (0.19%)
BR30 24,661 Decreased By ▼ -32.29 (-0.13%)
KSE100 44,934 Decreased By ▼ -9.52 (-0.02%)
KSE30 18,375 Decreased By ▼ -7.52 (-0.04%)

Coronavirus
VERY HIGH
Pakistan Deaths
18,537
10824hr
Pakistan Cases
845,833
419824hr
Sindh
288,680
Punjab
312,522
Balochistan
22,900
Islamabad
77,065
KPK
121,728
Business & Finance

Britain asks regulator to assess Pfizer vaccine for suitability

  • Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus.
  • This is another important step forward in tackling this pandemic," he said. "If a vaccine is approved it will, of course.
21 Nov 2020

LONDON: Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.

Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.3 million worldwide and crippled the global economy.

Britain's health minister, Matt Hancock, said the government had taken the step after the two companies applied for emergency use authorisation in the United States.

"That has given us the confidence ... formally to start the process here," he told a news conference.

"This is another important step forward in tackling this pandemic," he said. "If a vaccine is approved it will, of course, be available across the UK from our NHS (National Health Service), free at the point of delivery, according to need, not ability to pay."

Hancock said Pfizer-BioNTech have already starting supplying data to the medical regulator and will submit more in the coming days.

Pfizer spokesman Andy Widger said that the company is continuing to work closely with the MHRA and is in the process of providing the data to allow the regulator to make a full assessment.

The MHRA has launched an accelerated review of the shot, to speed up the process of approving a successful vaccine in the country, by allowing researchers to submit findings in real time, without waiting for studies to conclude.

The aim of the "rolling reviews" is to speed up evaluations of promising medicines during the pandemic while maintaining the same standards of safety and effectiveness.

Britain expects to have 10 million doses of the vaccine, enough to protect 5 million people, by the end of the year if regulators approve it.

Health officials stressed that the MHRA was independent and highly regarded. Jonathan Van Tam, England's deputy chief medical officer, said the MHRA would work "at the speed of science".